TP53 and prostate neoplasm: Moreover, as PIN formation, severity and tumor progression were highly variable in the AP amongst mice and glands of a given mouse (Supplementary Fig. 1E and F), these results show that p53 loss does not prevent PECs’ senescence, and underline lobe-specific prostate tumor progression.